| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.60B | 2.59B | 2.31B | 2.73B | 2.36B | 1.51B |
| Gross Profit | 608.32M | 609.75M | 548.05M | 647.27M | 633.01M | 338.88M |
| EBITDA | 242.86M | 249.74M | 221.43M | 296.00M | 326.66M | 206.41M |
| Net Income | 149.87M | 154.39M | 130.29M | 213.31M | 203.02M | 93.65M |
Balance Sheet | ||||||
| Total Assets | 4.35B | 4.36B | 4.15B | 4.43B | 4.38B | 3.44B |
| Cash, Cash Equivalents and Short-Term Investments | 726.22M | 528.18M | 669.15M | 696.31M | 1.20B | 1.02B |
| Total Debt | 15.29M | 17.54M | 19.93M | 27.72M | 70.73M | 102.01M |
| Total Liabilities | 1.20B | 1.27B | 1.08B | 1.20B | 1.37B | 764.26M |
| Stockholders Equity | 3.15B | 3.08B | 3.05B | 3.21B | 3.00B | 2.66B |
Cash Flow | ||||||
| Free Cash Flow | -99.24M | -170.49M | 85.94M | -390.33M | 200.74M | 167.24M |
| Operating Cash Flow | -6.34M | -98.87M | 149.87M | -259.76M | 241.78M | 185.54M |
| Investing Cash Flow | 6.55M | -116.41M | -14.94M | -128.76M | -40.33M | 204.18M |
| Financing Cash Flow | -78.50M | -59.10M | -123.48M | -151.90M | -94.61M | -23.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$8.53B | 10.00 | 10.93% | 1.57% | -13.95% | -13.61% | |
75 Outperform | HK$32.56B | 9.88 | 14.66% | 3.32% | 16.15% | 17.32% | |
73 Outperform | HK$15.12B | 12.66 | 13.39% | 3.23% | 2.87% | 17.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$1.02B | 4.73 | 4.79% | 7.16% | 17.21% | 29.75% | |
58 Neutral | HK$8.92B | 7.99 | 8.82% | 2.50% | 11.18% | 46.57% | |
44 Neutral | HK$14.67B | -168.92 | -4.53% | ― | 36.55% | 32.06% |